ADARx Pharmaceuticals, Inc. (ADRX)

NASDAQ Healthcare Biotechnology

ADARx Pharmaceuticals, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in San Diego, CA, US. The stock last traded at $14.96, down 7.02% on the session, giving a market capitalisation of $1.66B. Its beta of 0.00 implies it has historically moved less than the broad market.

ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.

ADARx Pharmaceuticals, Inc. is most often compared with the following Healthcare names: